News
A new review of clinical trial data finds evidence that GLP-1 drugs can meaningfully reduce dementia risk in people with type ...
Two studies suggested the diabetes/weight-loss drug may have a beneficial side effect—but more work is needed to confirm this ...
The study supports prior research that found the same thing.
It’s possible that they may play a role as a preventative measure in the future,” said Dr. Catriona Reddin told The Post.
A recent survey reveals the foods that people are less likely to eat once they start taking GLP-1 medications like Ozempic.
GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.
Board-certified rheumatologist Dr. Mahsa Tehrani discusses President Donald Trump’s possible 25% tariff on overseas ...
The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...
Popular weight loss drugs may do more than curb appetite — they may also help reduce the risk of dementia, according to new research.
Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...
Weight loss drugs like Ozempic gained popularity for managing obesity, diabetes, and related chronic conditions, a new study ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results